{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:56:03Z","timestamp":1761663363806,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.medmal.2015.03.003","type":"journal-article","created":{"date-parts":[[2015,4,5]],"date-time":"2015-04-05T18:40:46Z","timestamp":1428259246000},"page":"169-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Non-carbapenem therapy of urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-3131","authenticated-orcid":false,"given":"A.","family":"de La Blanchardi\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Darg\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Daurel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Saint-Lorant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Cattoir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2015.03.003_bib0070","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/671740","article-title":"Secular trends in Gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009","volume":"34","author":"Zilberberg","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.medmal.2015.03.003_bib0075","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk factors for community-acquired urinary tract infections caused by ESBL-producing Enterobacteriaceae\u00a0\u2013\u00a0a case-control study in a low prevalence country","volume":"8","author":"Soraas","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.medmal.2015.03.003_bib0080","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medmal.2015.03.003_bib0085","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1128\/AAC.45.12.3548-3554.2001","article-title":"Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","volume":"45","author":"Thomson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.03.003_bib0090","first-page":"5","article-title":"Extended-spectrum beta-lactamase producing bacteria in a tertiary care hospital in Madrid: epidemiology, risk factors and antimicrobial susceptibility patterns","author":"Rubio-Perez","year":"2012","journal-title":"Emerg Health Threats J"},{"key":"10.1016\/j.medmal.2015.03.003_bib0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","article-title":"Extended-spectrum \u03b2-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy","volume":"39","author":"Meier","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2015.03.003_bib0100","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1128\/AAC.02516-12","article-title":"Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum \u03b2-lactamase in a large US medical center","volume":"57","author":"Hayakawa","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2015.03.003_bib0105","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1742-1241.2012.02991.x","article-title":"Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria","volume":"66","author":"Briongos-Figuero","year":"2012","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.medmal.2015.03.003_bib0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"Beta-lactam\/beta-lactam inhibitor combinations for the treatment of bacteremia due to ESBL-producing Escherichia coli: a post-hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2015.03.003_bib0115","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2015.03.003_bib0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ijantimicag.2012.08.003","article-title":"Nitrofurantoin in the treatment of to extended-spectrum \u03b2-lactamase-producing Escherichia coli-related lower urinary tract infection","volume":"40","author":"Tabaskan","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medmal.2015.03.003_bib0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medmal.2015.03.003_bib0130","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/civ003","article-title":"Carbapenem therapy is associated with improved survival compared to piperacillin-tazobactam for patients with ESBL bacteremia","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X15000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:13:32Z","timestamp":1759972412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X15000645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S0399077X15000645"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2015.03.003","relation":{},"ISSN":["0399-077X"],"issn-type":[{"type":"print","value":"0399-077X"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-carbapenem therapy of urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2015.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}